Form 8-K - Current report:
SEC Accession No. 0001683168-26-003446
Filing Date
2026-05-04
Accepted
2026-05-04 16:05:18
Documents
13
Period of Report
2026-05-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K valion_8k.htm   iXBRL 8-K 40317
2 TIVIC HEALTH EXECUTIVE EMPLOYMENT AGREEMENT valion_ex1001.htm EX-10.1 67555
3 PRESS RELEASE valion_ex9901.htm EX-99.1 14327
  Complete submission text file 0001683168-26-003446.txt   315533

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vbio-20260501.xsd EX-101.SCH 2990
5 XBRL LABEL FILE vbio-20260501_lab.xml EX-101.LAB 34915
6 XBRL PRESENTATION FILE vbio-20260501_pre.xml EX-101.PRE 22772
16 EXTRACTED XBRL INSTANCE DOCUMENT valion_8k_htm.xml XML 3382
Mailing Address 1305 E. HOUSTON STREET BUILDING 1, SUITE 311 SAN ANTONIO TX 78205
Business Address 1305 E. HOUSTON STREET BUILDING 1, SUITE 311 SAN ANTONIO TX 78205 (888)276-6888
Valion Bio, Inc. (Filer) CIK: 0001787740 (see all company filings)

EIN.: 814016391 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41052 | Film No.: 26937467
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)